Startup accelerator & VC Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | GO CAPITAL Venture Capital and Private Equity Principals | Other 28 Apr 2021 | | |
 | Atomico Venture Capital and Private Equity Principals | Other 3 May 2018 | | |
 | Truffle Capital fintech, Venture Capital and Private Equity Principals | Other 28 Apr 2021 | | |
 | Newfund Venture Capital and Private Equity Principals | Other 16 Apr 2024 | | |
 | Innovation Forum biotech, deeptech, Biotechnology Research | Other 7 Nov 2019 | | |
 | Labiotech.eu Online Audio and Video Media | Other 7 Nov 2019 | | |
 | European Investment Fund (EIF) Financial Services | Other 28 Feb 2022 | | |
 | Creathor Ventures fintech, Venture Capital and Private Equity Principals | Other 25 Sep 2019 | | |
 | Private Equity Magazine Newspaper Publishing | Other 3 May 2024 | | |
 | Provence Angels fintech, Civic and Social Organizations | Other 20 Dec 2018 | | |